Gemcitabine-Fused microRNA Shows Promise Against Chemoresistant Colorectal Cancer in Preclinical Models
A gemcitabine-modified tumor-suppressor microRNA called Gem-miR-15a overcame 5-FU and oxaliplatin resistance in preclinical colorectal cancer models with low-nanomolar potency and ...
